Molecular mechanism of hemosorption

Iakubovskaia R.I., Utkin M.M., Nemtsova E.R., Kazachkina N.I., Avdeev G.I., Borisov V.I., Mamontov A.S.
PubMed Id: 2238521
Year: 1990  Volume: 36  Issue: 4  Pages: 11-15
Several humoral and intracellular components of blood were investigated in patients with esophageal carcinoma treated with preventive hemosorption + chemotherapy, and also in patients with purulent complications after surgery before hemosorption, during hemosorption and 3 hrs, 1, 3 and 7 days after hemosorption. It was demonstrated that during hemosorption and in the first days following it no significant changes occurred either in blood count or in protein content, protein composition, levels of alpha 1-AT, IgG, IgA and IgM in blood plasma. Preventive hemosorption did not cause hypo- or dysproteinemias in these patients. Hemosorption led to normalization of certain biochemical indices of blood: increase in BAEE activity and decrease in the level of middle molecular toxins, which indicated the reduction of endotoxicosis in patients. During hemosorption there was a marked (100-200 times) increase in blood plasma of lactoferrin, which is a component of specific granules in neutrophils. It is assumed that the leading modifying mechanism of action of hemosorption is an output of physiologically active components the main of which is lactoferrin.
Download PDF:  

Iakubovskaia, R. I., Utkin, M. M., Nemtsova, E. R., Kazachkina, N. I., Avdeev, G. I., Borisov, V. I., Mamontov, A. S. (1990). Molecular mechanism of hemosorption. Voprosy Meditsinskoi Khimii, 36(4), 11-15.
 2002 (vol 48)
 2001 (vol 47)
 2000 (vol 46)
 1999 (vol 45)
 1998 (vol 44)
 1997 (vol 43)
 1996 (vol 42)
 1995 (vol 41)
 1994 (vol 40)
 1993 (vol 39)
 1992 (vol 38)
 1991 (vol 37)
 1990 (vol 36)
 1989 (vol 35)
 1988 (vol 34)
 1987 (vol 33)
 1986 (vol 32)
 1985 (vol 31)